Supporting the world’s top generic companies calls for state-of-the-art R&D infrastructure that keeps pace with the demands of evolving regulation.
We combine technology, infrastructure and human resources to consistently develop new products and create patentable innovation.
The Formulation R&D center based at Nashik, Maharashtra, India is engaged in the research of specialty and branded formulations for global markets. It is equipped to research on a variety of dosage forms such as oral solid dosages, semi-solids, parenteral and aerosols for various indications. The center also is engaged in the research and development of Injections and Liposomal products.
New Biologic Entity (NBE) Research in Switzerland
Investing in groundbreaking technologies, platforms and facilities ensures that we will continue to drive innovation within our pipeline. In 2006, the Glenmark Biologics Research Centre opened in Neuchâtel, Switzerland. The Swiss research centre focuses on the discovery and development of new biological entities comprising GBR 830, an anti-OX40 monoclonal antibody in development to treat atopic dermatitis. Operations in Switzerland include end-to-end capabilities to discover New Biological Entities (NBEs) and develop them from inception through preclinical and clinical studies.
With a world-class, GMP-certified manufacturing line, our Swiss site is well-positioned to fully serve the company’s growth in biologics research and development. The facility provides Glenmark with a full suite of in-house capabilities necessary for early production of investigational biologics medicines, including cell line development, bioassay development and antibody engineering, as well as up- and downstream development.
New Chemical Entity (NCE) Research in India
Located in Mahape, on the outskirts of Mumbai, India, our R&D centre has end-to-end capabilities for discovery and development of New Chemical Entities (NCEs), from target selection to clinical development. The 125,000-square-foot research facility is equipped with the state-of-the-art infrastructure required to carry out research activities like medicinal chemistry, process and analytical chemistry, in vitro and in vivo studies, as well as project management.